USPTO serial 79047695
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Zakritoé akzionérnoé obtschestvo; "Evalar"
Biïsk; Altaïskiy kraï, RU
Other trademarks owned by Zakritoé akzionérnoé obtschestvo; "Evalar"
Zakritoé akzionérnoé obtschestvo; "Evalar"
RU
Other trademarks owned by Zakritoé akzionérnoé obtschestvo; "Evalar"
Zakritoé akzionérnoé obtschestvo; "Evalar"
RU
Other trademarks owned by Zakritoé akzionérnoé obtschestvo; "Evalar"
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
CRAIG M. SPIERER
CRAIG M. SPIERER Harris Beach PLLC333 Earle Ovington Blvd., Suite 901Uniondale, NY 11553UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 003 | [ Essential oils for personal use; essential oils for food flavorings; deodorants for personal use; greases for cosmetic purposes; cosmetic pencils; cosmetic creams; hair lotions; lotions for cosmetic purposes; beauty masks; oils for perfumes and scents; oils for cosmetic purposes; toilet water; essential oils; ethereal oils; essential oils of cedarwood; oils for cleaning purposes; medicated soap; antiperspirant soaps; perfume oils; lipstick; bath oils for cosmetic purposes;cosmetic preparations for slimming purposes; nail care preparations; astringents for cosmetic purposes; sun tanning preparations; fragrant potpourris; depilatory wax; depilatories;depilatory preparations; cosmetic preparations for skin care; cosmetics; antiperspirants;shampoos ] | SECTION 71 - CANCELLED | — |
| 005 | [ Opium alkaloid preparations; aldehydes for the treatment of infections of genitourinary system, skin infections; formic aldehyde for use as disinfecting and deodorizing preparations; dietetic food adapted for medical use; amino acids for medical purposes; antibiotics; balms for medical purposes; bismuth subnitrate for pharmaceutical purposes; melissa water for the prevention and/or treatment of disorders of the nervous system; mineral water for the treatment of gastrointestinal disorders; dietary fiber as an additive of food products; guaiacol for the treatment of the respiratory system disorders; Hematogen for the treatment of iron-deficiency anemia; gentian for the treatment of gastrointestinal disorders; mustard, namely, mustard plasters for external use as a counterirritant, circulation stimulant; air deodorants; digitalin for the treatment of disorders of the cardio-vascular system, namely, circulatory collapse, heart failure, heart rhythm disorders; ] mineral food supplements; [ food supplements for medical use; yeast for pharmaceutical purposes; gelatin capsules sold empty for pharmaceuticals; cod liver oil; iodine for pharmaceutical purposes; iodides for the treatment of hormonal disorders, namely, thyroid gland disorders; cream of tartar for external use as an antiperspirant powder; tartar for use as a laxative; wart pencils; ] dietetic supplements; [ nutritional additives for medical purposes; collodion for the treatment of wounds and scratches; medicated confectionery; barks for the treatment of disorders of the nervous, immune, cardio-vascular and metabolic systems, the respiratory and genitourinary systems, musculo-skeletal and inflammatory disorders; medicinal roots for the treatment of prostate hyperplasia, infections of urinary tract, infections of respiratory tract; starch for use as an adjuvant in manufacture of pharmaceutical preparations; dietetic supplements; nutritional additives for medical purposes; creosote for the treatment of tuberculosis; licorice and stick licorice for the treatment of disorders of the respiratory system, for the treatment of disorders of the immune system; medicines for alleviating constipation; pharmaceutical lotions for the treatment of skin diseases; for use as medicated hair care preparations; lupulin for the treatment of disorders of the nervous system, for use as a sedative; magnesia for use as a laxative, sedative, spasmolytic and anticonvulsant; liniments; antibiotic ointments; medicinal oils for the treatment of skin diseases, for use as medicated skin care preparations, as medicated hair care preparations; drugs for the treatment of cancer; medicines for the treatment of cancer; menthol for the treatment of itching, neuralgia, diseases of the respiratory system; medicinal drinks;, almond oil for the treatment of skin diseases for use as medicated skin care preparations and as medicated hair care preparations; milk ferments for the treatment of gastro-intestinal diseases, for the prevention and treatment of disorders of the immune system, the metabolic system; flour for use as an adjuvant in manufacture of pharmaceutical preparations; dietetic supplements; nutritional additives for medical purposes; mint for the treatment of the central nervous system and the gastro-intestinal system disorders; dietary drink mix for use as meal replacement; synthetic narcotics; herbal teas for the prevention and treatment of disorders of the nervous, immune, cardio-vascular and metabolic systems, the gastro-intestinal system, the respiratory and genitourinary systems, musculo-skeletal and inflammatory disorders, for use in dermatology, oncology, hematology, ophthalmology; eucalyptol for the treatment of bronchopulmonary diseases; pectin for the treatment of disorders of gastro-intestinal system; pepsin for the treatment of disorders of gastro-intestinal system; pepton for the treatment of disorders of gastro-intestinal system; pills for the prevention and treatment of disorders or diseases of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, the gastro-intestinal system, for the treatment of inflammatory disorders, of ocular disorders or diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, for the treatment of bacteria-based diseases, and for the treatment of diabetes; pomades for the treatment of herpes; pyrethrum powder for destroying parasites; preparations for destroying vermin and parasites; albuminous preparations for use as a meal substitute dietetic foods; ] vitamin preparations; [ therapeutic preparations for the bath, namely, bath salts for medical purposes; preparations for the treatment of burns; pharmaceutical preparations for treating dandruff; pharmaceutical preparations for skin care; preparations of lime for use as disinfecting and deodorizing preparations; medicinal preparations for stimulating hair growth; ] preparations of trace elements [ for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, the gastro-intestinal system, ] for use as dietetic supplements [, nutritional additives for medical purposes; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, the gastro-intestinal system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders, or the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, of mastopathy, of atherosclerosis, of allergy, and anti-infective preparations; antiviral preparations; antibiotics; antifungal preparations and vaccines; enzyme preparations for the treatment of disorders of gastro-intestinal system; ferments for medical use; chemical-pharmaceutical preparations for the treatment of disorders of the nervous system, the immune system, the vascular and metabolic systems, the respiratory and genitourinary systems, musculo-skeletal and inflammatory disorders or for use in dermatology, oncology, hematology, ophthalmology, for gastro-enterology, for the prevention and treatment of ocular disorders, for use as anti-infective, antiparasitic, antibiotic, anti-bacterial, antiviral and antifungal; pharmaceutical preparations for the treatment of chilblains; eye-wash; albuminous foodstuffs for medical purposes; dietetic foods adapted for medical purposes; hydrated chloral for use as an analgesic, anticonvulsant, hypnotic, sedative; chewing gum for medical purposes; tissues impregnated with pharmaceutical lotions; herbal teas for the treatment of asthma; fumigating pastilles for the treatment of migraine, wounds, sores; linseed for the treatment of cough, for the treatment of gastro-intestinal disorders, namely, chronic constipation, colitis, for use as immune stimulant; tobacco free cigarettes for medical use; syrups for the treatment of cough; turpentine for use as an ointment and bath for the treatment of neuralgia, myositis, lumbago, rheumatism; sleeping pills; bicarbonate of soda for the treatment of gastro-intestinal disorders, as an antacid for the treatment of rhinitis, conjunctivitis, stomatitis, laryngitis; mineral salts for medical purposes; medicated bath salts; medicines in the form of tonics for the treatment of depression; malt for the treatment of tuberculosis, asthenia, anaemia, metabolic acidosis; medicinal alcohol; analgesics; adjuvants for medical purposes; styptic preparations; appetite reducers for medical purposes; medical preparations for slimming purposes; mouthwashes for medical purposes; depuratives; remedies for perspiration; laxatives; purgatives; evacuants; dietary and nutritional supplements in the form of tonic; nervines for the treatment of disorders of the nervous system; pharmaceutical preparations for the treatment of digestive disorders; pastilles for the treatment of respiratory disorders, namely, diseases affecting mouth, throat and upper air passages; thymol for use as an antiseptic; smoking herbs as an aromatherapy means in the treatment of respiratory diseases and disorders, namely, asthma; medicinal herbs; tranquilizers; charcoal for the treatment of digestive disorders, namely, dyspepsia, meteorism, as a sorbent in the treatment of food poisoning; fennel for the treatment of digestive disorders, namely, dyspepsia, meteorism, for use as a cough expectorant; phenol for use as an antiseptic; phosphates for the treatment of musculo-skeletal system disorders, and support-locomotion system disorders, namely, joint diseases, for the treatment of diseases affecting teeth; flowers of sulphur for the treatment of skin diseases, for use as an antiparasitic; herb teas for medicinal purposes; eucalyptus for the treatment of respiratory disorders, namely, cough; extract of hops for use as a hypnotic, sedative; esters for use in the treatment of disorders of the nervous, immune, cardio-vascular and metabolic systems, the respiratory and genitourinary systems, musculo-skeletal and inflammatory disorders or for use in dermatology, oncology, hematology, ophthalmology; pharmaceutical preparations for gastro-enterology, for the prevention and treatment of ocular disorders; cellulose esters for use in the treatment of disorders of the nervous, immune, cardio-vascular and metabolic systems, the respiratory and genitourinary systems, musculo-skeletal and inflammatory disorders or for use in dermatology, oncology, hematology, ophthalmology ] | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 15, 2024 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Nov 15, 2024 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Sep 12, 2020 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Aug 10, 2020 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Aug 10, 2020 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jul 15, 2020 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Nov 15, 2019 | C71T | CANCELLED SECTION 71 | — |
| Apr 14, 2018 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| May 2, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 13, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 5, 2016 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Dec 30, 2015 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Dec 30, 2015 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Nov 3, 2015 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 3, 2015 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - MAILED | — |
| Mar 3, 2015 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Mar 2, 2015 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 27, 2015 | 715F | REGISTERED - SEC. 71 & SEC. 15 FILED | — |
| Feb 27, 2015 | 15AF | REGISTERED - SEC. 15 AFFIDAVIT FILED | — |
| Feb 27, 2015 | 71AF | REGISTERED-SEC.71 FILED | — |
| Feb 27, 2015 | PAPER RECEIVED | — | |
| May 15, 2014 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| May 18, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 29, 2009 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 29, 2009 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 14, 2009 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 14, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 6, 2009 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Nov 6, 2008 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Oct 21, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 1, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 15, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 15, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 25, 2008 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Aug 25, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 19, 2008 | PAPER RECEIVED | — | |
| Jun 18, 2008 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 18, 2008 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 27, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 27, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 27, 2008 | ALIE | ASSIGNED TO LIE | — |
| May 27, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 8, 2008 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 15, 2008 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 15, 2008 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 15, 2008 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 14, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 7, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 7, 2008 | NWAP | NEW APPLICATION ENTERED | — |
| Jan 3, 2008 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |